New scholarship by West Virginia University College of Law professor S. Sean Tu appears in the latest issue of the Berkeley Technology Law Journal. The article, "Antibody Patents: Use of the Written Description and Enablement Requirements at the Patent & Trademark Office" is now published in volume 38, issue 1 of the journal. Professor Tu co-authored the work with Professor Christopher Holman of the University of Missouri - Kansas City School of Law.
From the abstract:
West Virginia University College of Law professor S. Sean Tu recently published a new Research Letter in JAMA. The article, titled "Changes in the Number of Continuation Patents on Drugs Approved by the FDA", is the result of a comprehensive study of all drug patents from 2000-2015. Professor Tu and co-authors examine the frequency of continuation patents on brand-name drugs and how they contribute to the creation of patent thickets. Professor Tu co-authored this new work with Aaron S. Kesselheim, and William B. Feldman of Brigham and Women’s Hospital in Boston, Massachusetts, and with Kathrine Wetherbee of Duke University. It was published online by the journal on August 1, 2023.
Professor Tu has also been interviewed by media outlets on this topic following the article's publication:
West Virginia University College of Law professor S. Sean Tu recently published a new article in Nature Biotechnology. The article, titled "The prevalence of drug patent term extensions in the United States, 2000–2018," analyzes the impact of patent term extension (PTE) on drug market exclusivity. Professor Tu co-authored with work with Victor L. Van de Wiele, Aaron S. Kesselheim, and Sarosh Nagar, all of whom are affiliated with Brigham and Women’s Hospital in Boston, Massachusetts, It was published online by the journal on July 14, 2023.
Find more of Professor Tu's scholarship on SSRN.
West Virginia University College of Law professor S. Sean Tu recently published a new Research Letter in JAMA. The article, titled "Five-Year Sales for Newly Marketed Prescription Drugs With and Without Initial Orphan Drug Act Designation," analyzes sales revenue earned in the first 5 years for drugs with and without an initial orphan designation. Professor Tu co-authored with work with Sarosh Nagar; Aaron S. Kesselheim, Zhigang Lu, and Benjamin N. Rome, all of whom are affiliated with Brigham and Women’s Hospital in Boston, Massachusetts, It was published online by the journal on May 9, 2023.
Find more of Professor Tu's scholarship on SSRN.
West Virginia College of Law professor S. Sean Tu recently published an article in the latest issue of Landslide, a magazine published by the American Bar Association Section of Intellectual Property Law. The article is titled "Gender Inequality in Pharmaceutical Patent Law" and appears in the March/April 2023 issue. Tess Hardesty, a student at the College of Law co-authored the work.
From the abstract:
